Aurobindo Pharma surges despite reporting 14% fall in Q2 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Aurobindo Pharma is currently trading at Rs. 683.05, up by 10.65 points or 1.58% from its previous closing of Rs. 672.40 on the BSE.
The scrip opened at Rs. 685.00 and has touched a high and low of Rs. 713.25 and Rs. 677.00 respectively. So far 384129 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1063.75 on 11-May-2021 and a 52 week low of Rs. 660.10 on 24-Aug-2021.
Last one week high and low of the scrip stood at Rs. 713.25 and Rs. 662.40 respectively. The current market cap of the company is Rs. 39711.99 crore.
The promoters holding in the company stood at 51.83%, while Institutions and Non-Institutions held 37.23% and 10.93% respectively.
Aurobindo Pharma has reported a fall of 75.19% in its net profit at Rs 197.68 crore for the quarter ended September 30, 2021 as compared to Rs 796.93 crore for the same quarter in the previous year. Total income of the company decreased by 35.41% at Rs 2965.55 crore for Q2FY22 as compared Rs 4591.67 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 13.69% in its net profit at Rs 696.71 crore for the quarter ended September 30, 2021 as compared to Rs 807.25 crore for the same quarter in the previous year. Total income of the company decreased by 7.63% at Rs 6038.50 crore for Q2FY22 as compared Rs 6537.19 crore for the corresponding quarter previous year.
